SKGF_Presentation_IP Issues in Nanotechnology - A View from Around the World_2004

SKGF_Advisory_Living in a Post KSR World_2007

SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007

SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes And Other Reform Initiatives_2006

SKGF_Advisory_USPTO Proposed Rule Changes Impact on Small Business_2006

SKGF_Advisory_Therapeutic Antibodies Top Three Intellectual Property Issues_2008

SKGF_Advisory_The Impact of Patent Reform on Nanotech_2006

SKGF_Advisory_Consider a Prosecution History Disclaimer for Every Continuation Application_2007

SKGF_Presentation_Left Turns Only - Making Sense of Nanotech IP Strategy_2004

SKGF_Presentation_Computer-Related Patent Law, Strategy and Trends - Release 1.8_2004

SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007

SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007

SKGF_Presentation_SKGF Nanotube Patent Study_2004

SKGF_Presentation_Patenting Antibodies_2006

SKGF_Presentation_Optimizing Reexamination Patent Strategy at the U.S. Patent Office for your IP Business Model_2008

SKGF_Presentation_Patent Licensing in the Wake of MedImmune, eBay, KSR and Microsoft_2007

SKGF_Presentation_Stem Cells The Patent Landscape_2005

SKGF_Presentation_USPTO Patent Examination Reform and Proposed Rule Changes-2006

SKGF_Presentation_Biosimilars: Where Do We Stand and Where Are We Headed?_2008

SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal Maze_06